1 December 2022
—
That’s a wrap! A review of bladder cancer news in 2022
Bladder cancer~Urothelial cancer
EM-87605
EM-86762
EM-86801
5 October 2022
- 91 Minutes
Exploring questions in metastatic prostate cancer
Janssen sponsored industry session at ESMO 2022
Prostate cancer~september2022updates
EM-106735
5 October 2022
- 88 Minutes
Precision approaches in EGFR-mutant NSCLC: Optimising outcomes for patients
Janssen sponsored industry session at ESMO 2022
Lung cancer~september2022updates
EM-106732
13 September 2022
- 68 Minutes
An evolving landscape: EGFR-mutant NSCLC management updates from September 2022
Lung cancer~september2022updates
EM-86796
4 September 2022
- 88 Minutes
Practical examples of precision medicine in cancer care
Janssen sponsored industry session at ECP 2022
Lung cancer
EM-105087
7 August 2022
- 62 Minutes
Expanding horizons for the targeted management of EGFR-mutant NSCLC
Janssen sponsored industry session at WCLC 2022
Lung cancer
EM-103048
13 July 2022
- 60 Minutes
Enquiring minds: a comprehensive overview of genomic profiling from tissue to liquid biopsy
Lung cancer
EM-86791
1 July 2022
- 109 Minutes
Looking towards the future: considerations for treatment strategies across the spectrum of advanced prostate cancer
Janssen sponsored industry session at EAU 2022
Prostate cancer
EM-86726